NASDAQ : GERN

Geron Corporation — Financial statements

Healthcare · Biotechnology · United States

Last price 0.9462 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 607.91M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Geron Corporation (GERN) reported revenue of 204.56M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue204.56M183.88M76.99M237.00K596.00K1.39M
Cost of Revenue84.89M76.18M104.99M125.05M95.52M84.53M
Gross Profit119.67M107.70M-28.00M-124.81M-94.92M-83.14M
Selling, General & Admin154.96M159.26M145.73M69.14M43.63M30.86M
Operating Expenses154.96M159.26M145.73M69.14M43.63M30.86M
Operating Income-35.28M-51.55M-173.73M-193.94M-138.55M-114.00M
Interest Expense-30.23M-32.66M-18.50M-8.31M-6.88M-3.74M
Interest & Investment Income14.70M18.12M19.61M18.15M2.53M527.00K
Other Non Operating Income (Expenses)-314.00K-375.00K-236.00K-23.00K1.00M-100.00K
EBT Excluding Unusual Items-51.13M-66.47M-172.87M-184.13M-141.90M-117.31M
Merger & Restructuring Charges-16.48M-17.03M
Gain (Loss) on Sale of Investments1.20M
Other Unusual Items-1.71M
Pretax Income-67.61M-83.50M-174.57M-184.13M-141.90M-116.11M
Net Income-67.61M-83.50M-174.57M-184.13M-141.90M-116.11M
Net Income to Common-67.61M-83.50M-174.57M-184.13M-141.90M-116.11M
Shares Outstanding (Basic)668.66M666.66M646.03M570.65M380.78M327.63M
Shares Outstanding (Diluted)668.66M666.66M646.03M570.65M380.78M327.63M
EPS (Basic)-0.10-0.13-0.27-0.32-0.37-0.35
EPS (Diluted)-0.10-0.13-0.27-0.32-0.37-0.35
Free Cash Flow-114.76M-111.09M-219.30M-168.57M-127.81M-95.76M
Free Cash Flow Per Share-0.17-0.17-0.34-0.29-0.34-0.29
Gross Margin58.50%58.57%-36.37%
Operating Margin-17.25%-28.04%-225.64%-81,832.91%-23,246.64%-8,183.70%
Profit Margin-33.05%-45.41%-226.73%-77,690.72%-23,808.89%-8,335.39%
Free Cash Flow Margin-56.10%-60.41%-284.83%-71,127.85%-21,444.63%-6,874.59%
EBITDA-34.80M-51.08M-173.19M-193.50M-138.26M-113.78M
EBITDA Margin-17.01%-27.78%-224.93%
D&A For EBITDA485.00K474.00K546.00K442.00K288.00K215.00K
EBIT-35.28M-51.55M-173.73M-193.94M-138.55M-114.00M
EBIT Margin-17.25%-28.04%-225.64%
Revenue as Reported20.68M

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents62.64M77.56M79.02M70.02M56.84M34.87M
Short-Term Investments238.21M280.36M327.55M263.68M115.90M148.85M
Cash & Short-Term Investments300.85M357.92M406.57M333.70M172.75M183.72M
Accounts Receivable51.64M36.99M35.95M
Other Receivables1.86M2.24M2.85M1.66M3.14M1.76M
Receivables53.50M39.23M38.80M1.66M3.14M1.76M
Inventory123.60M116.64M38.71M
Prepaid Expenses6.50M4.61M5.05M4.88M3.99M1.36M
Restricted Cash1.89M1.88M1.86M1.11M364.00K364.00K
Total Current Assets486.34M520.27M490.99M341.35M180.25M187.21M
Property, Plant & Equipment2.85M3.04M4.19M4.73M4.94M5.38M
Long-Term Investments24.12M41.29M94.52M43.30M28.65M
Other Long-Term Assets5.70M5.95M4.08M4.70M5.39M4.80M
Total Assets519.01M570.54M593.78M394.08M190.57M226.03M
Accounts Payable8.80M11.26M8.60M6.16M10.19M6.69M
Accrued Expenses39.82M81.84M58.36M54.07M44.63M37.93M
Current Portion of Long-Term Debt46.89M20.95M
Current Portion of Leases1.01M1.00M974.00K949.00K925.00K901.00K
Other Current Liabilities20.69M17.45M20.37M
Total Current Liabilities70.33M111.54M88.30M108.07M76.69M45.52M
Long-Term Debt120.13M119.55M118.48M35.05M30.21M49.83M
Long-Term Leases1.00M1.45M2.27M3.01M3.67M4.27M
Other Long-Term Liabilities108.93M112.13M104.42M
Total Liabilities300.39M344.67M313.46M146.13M110.58M99.62M
Common Stock642.00K640.00K606.00K545.00K390.00K324.00K
Additional Paid-In Capital2.09B2.08B2.05B1.84B1.49B1.40B
Retained Earnings-1.88B-1.86B-1.77B-1.60B-1.41B-1.27B
Comprehensive Income & Other-339.00K269.00K261.00K185.00K-219.00K-173.00K
Shareholders' Equity218.61M225.87M280.32M247.95M80.00M126.42M
Total Liabilities & Equity519.01M570.54M593.78M394.08M190.57M226.03M
Total Debt122.14M121.99M121.72M85.90M55.75M55.00M
Net Cash (Debt)202.83M277.22M379.37M291.10M116.99M157.38M
Net Cash Per Share0.300.420.590.510.310.48
Filing Date Shares Outstanding642.47M640.54M636.90M546.06M508.72M323.73M
Total Common Shares Outstanding642.47M639.86M606.39M544.91M390.26M323.73M
Working Capital416.01M408.73M402.69M233.28M103.55M141.69M
Book Value Per Share0.340.350.460.460.200.39
Tangible Book Value218.61M225.87M280.32M247.95M80.00M126.42M
Tangible Book Value Per Share0.340.350.460.460.200.39
Machinery2.96M2.88M2.27M1.55M1.17M
Leasehold Improvements129.00K129.00K135.00K135.00K129.00K

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-67.61M-83.50M-174.57M-184.13M-141.90M-116.11M
Depreciation & Amortization1.25M1.20M1.22M1.03M868.00K783.00K
Other Amortization1.14M1.07M1.09M1.33M893.00K
Loss (Gain) From Sale of Investments-4.75M-6.92M-9.68M-11.15M-965.00K1.42M
Stock-Based Compensation22.42M26.75M31.32M19.35M8.27M8.17M
Provision & Write-off of Bad Debts-892.00K-50.00K-251.00K
Other Operating Activities23.17M18.95M3.94M-1.23M
Change in Accounts Receivable-14.14M-991.00K-35.70M
Change in Inventory-60.81M-77.92M-37.97M
Change in Accounts Payable578.00K2.66M2.44M-4.03M3.50M-232.00K
Change in Other Net Operating Assets-14.73M7.72M634.00K10.09M1.52M10.75M
Operating Cash Flow-114.38M-111.04M-218.62M-167.74M-127.38M-95.56M
Capital Expenditures-386.00K-49.00K-680.00K-830.00K-431.00K-207.00K
Investment in Securities95.03M107.30M-105.32M-179.49M62.50M72.15M
Investing Cash Flow94.64M107.25M-106.00M-180.32M62.07M71.95M
Long-Term Debt Issued121.12M29.70M24.89M
Long-Term Debt Repaid-86.55M
Net Debt Issued (Repaid)34.57M29.70M24.89M
Issuance of Common Stock4.73M2.27M174.81M332.32M87.26M23.66M
Other Financing Activities125.00M
Financing Cash Flow4.73M2.27M334.37M362.02M87.26M48.56M
Foreign Exchange Rate Adjustments-70.00K87.00K-12.00K-27.00K22.00K
Net Cash Flow-15.07M-1.44M9.74M13.93M21.97M24.95M
Free Cash Flow-114.76M-111.09M-219.30M-168.57M-127.81M-95.76M
Free Cash Flow Margin-56.10%-60.41%-284.83%-71,127.85%-21,444.63%-6,874.59%
Free Cash Flow Per Share-0.17-0.17-0.34-0.29-0.34-0.29
Levered Free Cash Flow-78.37M-78.36M-137.87M-100.51M-74.68M-49.29M
Unlevered Free Cash Flow-60.62M-59.02M-126.30M-96.40M-71.70M-47.85M
Cash Interest Paid11.71M11.71M10.36M7.02M5.15M
Change in Working Capital-89.10M-68.54M-70.60M6.06M5.03M10.52M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization596.92M842.63M2.14B1.15B922.59M392.78M
Enterprise Value394.10M544.95M1.85B820.54M783.30M217.26M
Last Close Price0.931.323.542.112.421.22
Forward PE82.2210.0610.0610.0610.0610.06
PS Ratio2.924.5827.794,834.871,547.97281.96
PB Ratio2.733.737.634.6211.533.11
P/TBV Ratio2.733.737.634.6211.533.11
EV/Sales Ratio1.932.9624.033,462.181,314.27155.97
Debt / Equity Ratio0.560.540.430.350.700.43
Net Debt / Equity Ratio-0.93-1.23-1.35-1.17-1.46-1.25
Net Debt / EBITDA Ratio5.835.432.191.500.851.38
Net Debt / FCF Ratio1.772.501.731.730.921.64
Asset Turnover0.380.320.160.000.000.01
Inventory Turnover0.880.98
Quick Ratio5.043.565.043.102.294.08
Current Ratio6.924.665.563.162.354.11
Return on Equity (ROE)-28.28%-32.99%-66.09%-112.29%-137.49%-68.84%
Return on Assets (ROA)-4.11%-5.54%-21.98%-41.47%-41.57%-28.69%
Return on Capital Employed (ROCE)-7.90%-11.20%-34.40%-67.80%-121.70%-63.20%
Earnings Yield-10.88%-9.91%-8.16%-16.07%-15.38%-29.56%
FCF Yield-19.23%-13.18%-10.25%-14.71%-13.85%-24.38%
Buyback Yield / Dilution-0.60%-3.19%-13.21%-49.86%-16.22%-20.69%